Spero Therapeutics (SPRO) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$47.0M

Revenue (quarter)

—

Revenue growth (year over year)

—

Gross profit (trailing twelve months)

$47.0M

Gross margin

100.00%

Net income (trailing twelve months)

$7.4M

Net income (quarter)

−$9.6M

Net income growth (year over year)

−461.88%

Net margin

15.71%

Return on equity

19.17%

EPS (trailing twelve months)

$0.14

Book value per share

$0.76

P/E (trailing twelve months)

8.83

Price to book

1.48

Debt to assets

16.23%

Payout ratio

—

Dividend yield

—

Company profile

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

• Is Spero Therapeutics (SPRO) profitable?

  Yes. Spero Therapeutics earned $7.4M in net income over the trailing twelve months, a net margin of 15.71%.

• How much revenue does Spero Therapeutics (SPRO) make?

  Spero Therapeutics generated $47.0M in revenue over the trailing twelve months.

• What is SPRO's P/E ratio?

  Spero Therapeutics trades at 8.8 times trailing twelve-month earnings, on an EPS of $0.14.

• How do I buy stock in Spero Therapeutics (SPRO)?

  SPRO trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.